🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will determine the relative abuse potential of intact and chewed...
Status
Completed
Location
Lifetree Clinical Research
Start Date
2013-11
Trial ID
NCT01986283
Treatments Being Tested
To evaluate the dose proportionality of 5 mg, 20 mg and 40 mg of PF 0034543...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-04
Trial ID
NCT02089295
To Compare The Bioavailability Of 40 Mg Doses Of Pf-00345439 Modified Formu...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-04
Trial ID
NCT02059915
To estimate the effects of food on oxycodone pharmacokinetics after adminis...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-08
Trial ID
NCT01924676
To Estimate Bioavailability Of 40 Mg Doses Of Pf-00345439 Formulation K Und...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-07
Trial ID
NCT02165930
Treatments Being Tested
This is an open-label (both the physician and healthy volunteer know which ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-03
Trial ID
NCT01552863
To estimate the effect of food on the pharmacokinetics and relative bioavai...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-04
Trial ID
NCT02117583
To estimate the pharmacokinetics and relative bioavailability of oxycodone ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-11
Trial ID
NCT01717027
To estimate the pharmacokinetics and relative bioavailability of oxycodone ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-04
Trial ID
NCT01552850
Long-Term Safety Of PF-00345439 (Oxycodone) In Patients With Moderate To Se...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT01559701
Treatments Being Tested